SEC Tracker
Get the app

Avalo Therapeutics AVTX

Avalo Therapeutics Announces 1-for-240 Reverse Stock Split

Form
8-K
Filed
Period
Importance
Notable
Document
8-K
Exhibit 99.1
Press release
  • Changes shareholder rights (3.03)
  • Amends its charter or bylaws (5.03)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Avalo Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Cue Biopharma CUE public float $52M, Jun 30, 2025
  2. Fitlife Brands FTLF public float $51M, Jun 30, 2025
  3. Immucell ICCC public float $51M, Jun 30, 2025
  4. iBio IBIO public float $58M, Dec 31, 2025
  5. Sutro Biopharma STRO public float $60M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.